Subscribe free

HPB & Spleen ·

New Benchmarks for Liver Surgery in Colorectal Metastases

Liver resection demonstrates strong oncologic outcomes for colorectal liver metastases (CRLM), with a 90-day mortality rate below 5%. One-year overall survival (OS) rates exceed 85% for most patients, dropping to 78% for those with ten or more metastases. Five-year OS rates range from 28% to 67%, depending on tumor burden. These findings establish critical benchmarks that can guide the evaluation of emerging treatment options like thermal ablation and transplantation.

Journal Article by Viganò L, Risi L (…) Adam R et 12 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →